Takefumi Suzuki

7.6k total citations
234 papers, 4.6k citations indexed

About

Takefumi Suzuki is a scholar working on Psychiatry and Mental health, Pharmacology and Clinical Psychology. According to data from OpenAlex, Takefumi Suzuki has authored 234 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 138 papers in Psychiatry and Mental health, 54 papers in Pharmacology and 29 papers in Clinical Psychology. Recurrent topics in Takefumi Suzuki's work include Schizophrenia research and treatment (108 papers), Treatment of Major Depression (52 papers) and Bipolar Disorder and Treatment (47 papers). Takefumi Suzuki is often cited by papers focused on Schizophrenia research and treatment (108 papers), Treatment of Major Depression (52 papers) and Bipolar Disorder and Treatment (47 papers). Takefumi Suzuki collaborates with scholars based in Japan, Canada and United States. Takefumi Suzuki's co-authors include Hiroyuki Uchida, Masaru Mimura, Koichiro Watanabe, Hiroyoshi Takeuchi, David C. Mamo, Haruo Kashima, Ariel Graff‐Guerrero, Gary Remington, Shinichiro Nakajima and Tarek K. Rajji and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and PLoS ONE.

In The Last Decade

Takefumi Suzuki

224 papers receiving 4.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Takefumi Suzuki Japan	37	2.6k	797	766	551	430	234	4.6k
Oliver Freudenreich United States	45	3.3k 1.3×	638 0.8×	1.0k 1.3×	948 1.7×	328 0.8×	182	5.9k
David G. Daniel United States	28	2.7k 1.0×	436 0.5×	678 0.9×	235 0.4×	524 1.2×	91	3.9k
Koichiro Watanabe Japan	31	1.8k 0.7×	621 0.8×	469 0.6×	273 0.5×	314 0.7×	185	3.5k
Jimmi Nielsen Denmark	41	3.1k 1.2×	593 0.7×	892 1.2×	418 0.8×	184 0.4×	153	5.1k
Julia Lappin Australia	37	2.2k 0.9×	447 0.6×	1.3k 1.7×	263 0.5×	346 0.8×	153	4.8k
Rafael Tabarés‐Seisdedos Spain	43	4.6k 1.7×	356 0.4×	1.0k 1.4×	662 1.2×	496 1.2×	157	6.5k
Steven D. Targum United States	36	2.1k 0.8×	1.0k 1.3×	1.1k 1.5×	393 0.7×	962 2.2×	134	5.5k
William V. Bobo United States	35	1.7k 0.7×	687 0.9×	697 0.9×	280 0.5×	369 0.9×	154	4.4k
María Paz García‐Portilla Spain	38	2.3k 0.9×	280 0.4×	1.4k 1.8×	307 0.6×	541 1.3×	271	4.7k
Richard Bruggeman Netherlands	41	2.7k 1.0×	328 0.4×	1.4k 1.8×	552 1.0×	895 2.1×	243	5.7k

Countries citing papers authored by Takefumi Suzuki

Since Specialization

Citations

This map shows the geographic impact of Takefumi Suzuki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takefumi Suzuki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takefumi Suzuki more than expected).

Fields of papers citing papers by Takefumi Suzuki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takefumi Suzuki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takefumi Suzuki. The network helps show where Takefumi Suzuki may publish in the future.

Co-authorship network of co-authors of Takefumi Suzuki

This figure shows the co-authorship network connecting the top 25 collaborators of Takefumi Suzuki. A scholar is included among the top collaborators of Takefumi Suzuki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takefumi Suzuki. Takefumi Suzuki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Misawa, Fuminari, et al.. (2024). Intentional non-adherence to antipsychotic medication in patients with schizophrenia. Schizophrenia Research. 274. 427–432.

Iwata, Yusuke, et al.. (2023). Psychological distress among early medical residents: A 2-year longitudinal cohort study over seven years in Japan. Comprehensive Psychiatry. 127. 152425–152425. 1 indexed citations

Suzuki, Takefumi, et al.. (2021). Single Versus Multiple Daily Dosing Regimens of Psychotropic Drugs for Psychiatric Disorders. The Journal of Clinical Psychiatry. 82(2). 5 indexed citations

Suzuki, Takefumi, et al.. (2019). Factors Associated With Delirium Following Electroconvulsive Therapy. Journal of Ect. 35(4). 279–287. 25 indexed citations

Nishiguchi, Koji M., Yasuhiro Ikeda, Kosuke Fujita, et al.. (2019). Phenotypic Features of Oguchi Disease and Retinitis Pigmentosa in Patients with S-Antigen Mutations. Ophthalmology. 126(11). 1557–1566. 25 indexed citations

Sawada, Kyosuke, Kazunari Yoshida, Yuya Mizuno, et al.. (2018). Impact of subjective vs. objective remission status on subjective cognitive impairments in depression. Journal of Affective Disorders. 246. 99–104. 10 indexed citations

Sakurai, Hitoshi, Takefumi Suzuki, Kimio Yoshimura, Masaru Mimura, & Hiroyuki Uchida. (2017). Predicting relapse with individual residual symptoms in major depressive disorder: a reanalysis of the STAR*D data. Psychopharmacology. 234(16). 2453–2461. 60 indexed citations

Ueno, Fumihiko, Shinichiro Nakajima, Takefumi Suzuki, et al.. (2015). Whether to Increase or Maintain Dosage of Mirtazapine in Early Nonimprovers With Depression. The Journal of Clinical Psychiatry. 76(4). 434–439. 3 indexed citations

Nakajima, Shinichiro, Hiroyuki Uchida, Robert R. Bies, et al.. (2015). Dopamine D_2/3Receptor Occupancy Following Dose Reduction Is Predictable With Minimal Plasma Antipsychotic Concentrations: An Open-Label Clinical Trial. Schizophrenia Bulletin. 42(1). sbv106–sbv106. 18 indexed citations

10.

Ishida, Takuto, Takefumi Suzuki, Koichiro Watanabe, et al.. (2014). Prophylactic use of heparin for deep vein thrombosis in restrained psychiatric patients: a chart review. General Hospital Psychiatry. 36(6). 690–693. 9 indexed citations

11.

Suzuki, Takefumi, Hiroyuki Uchida, Juri Saruta, et al.. (2014). Effects of Weekly One-Hour Hatha Yoga Therapy on Resilience and Stress Levels in Patients with Schizophrenia-Spectrum Disorders: An Eight-Week Randomized Controlled Trial. The Journal of Alternative and Complementary Medicine. 20(11). 823–830. 52 indexed citations

12.

Uchida, Hiroyuki, Robert R. Bies, Takefumi Suzuki, et al.. (2014). Predicting dopamine D2 receptor occupancy following antipsychotic dose reduction: a pilot PET study.. 34(2). 55–56. 1 indexed citations

13.

Moriguchi, Sho, Robert R. Bies, Gary Remington, et al.. (2013). Estimated Dopamine D2 Receptor Occupancy and Remission in Schizophrenia. Journal of Clinical Psychopharmacology. 33(5). 682–685. 21 indexed citations

14.

Suzuki, Takefumi, G. Remington, Robert R. Bies, et al.. (2013). Effects of Risperidone and Olanzapine Dose Reduction on Cognitive Function in Stable Patients With Schizophrenia: An Open-Label, Randomized, Controlled, Pilot Study. Schizophrenia Bulletin. 39(5). 993–998. 80 indexed citations

15.

Takeuchi, Hiroyoshi, Takefumi Suzuki, Robert R. Bies, et al.. (2013). Estimated dopamine D2 receptor occupancy from plasma concentrations of atypical antipsychotics and subjective experience/drug attitude in schizophrenia: An analysis of the CATIE data. Schizophrenia Research. 150(2-3). 373–379. 8 indexed citations

16.

Uchida, Hiroyuki, Takefumi Suzuki, Koichiro Watanabe, et al.. (2011). The evolution of antipsychotic switch and polypharmacy in natural practice — A longitudinal perspective. Schizophrenia Research. 130(1-3). 40–46. 48 indexed citations

17.

Ishida, Takuto, Hiroyuki Uchida, Takefumi Suzuki, et al.. (2011). Plasma substance P level in patients with schizophrenia: A cross‐sectional study. Psychiatry and Clinical Neurosciences. 65(5). 526–528. 4 indexed citations

18.

Uchida, Hiroyuki, et al.. (2009). Persistence and compliance to antidepressant treatment in patients with depression: A chart review. BMC Psychiatry. 9(1). 38–38. 150 indexed citations

19.

Takata, Minoru, Jingrong Lin, Satoshi Takayanagi, et al.. (2007). Genetic and epigenetic alterations in the differential diagnosis of malignant melanoma and spitzoid lesion. British Journal of Dermatology. 156(6). 1287–1294. 57 indexed citations

20.

Uchida, Hiroyuki, et al.. (2005). Combined Treatment With Sulpiride and Paroxetine for Accelerated Response in Patients With Major Depressive Disorder. Journal of Clinical Psychopharmacology. 25(6). 545–551. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact